Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The HIV-1 Env trimer is a complex, heavily glycosylated protein composed of three gp120 surface subunits non-covalently associated with three gp41 transmembrane subunits. It mediates virus entry by binding CD4 and co-receptors (CCR5 or CXCR4) on host cells. Stabilized soluble versions are engineered to maintain native-like structure outside membranes. Presenting these trimers as immunogens aims to guide B cell responses toward bnAb precursors by mimicking authentic epitope presentation seen during infection.
Immunogen to elicit broadly neutralizing antibodies
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Native-like HIV Envelope Glycoprotein Trimer (HIV Env trimer).